The Dr. N. Radhakrishnan International Centre for Medical Innovation (NRICMI) at Mahatma Gandhi University, Kottayam, is a premier research institution focused on advancing medical science and public health through cutting-edge research and innovation. NRICMI is committed to pioneering advancements in medical research by focusing on interdisciplinary research and fostering collaborations with academic, clinical, and industry leaders. NRICMI’s mission is to address pressing health challenges, such as chronic venous diseases, vascular health, antibiotic resistance, chronic wound management and regenerative medicine, by translating scientific findings into real-world solutions for the benefit of both local and global communities.
Medical Research: NRICMI seeks to develop advanced therapeutic solutions, including nanotechnology-based treatments and regenerative materials, to address complex health conditions such as chronic ulcers, antibiotic-resistant infections, and tissue regeneration.
Public Health: By aligning research priorities with community health needs, NRICMI’s projects are directed toward enhancing health outcomes.
Encouraging Translational Research: The center aims to bridge basic science with clinical applications, ensuring that discoveries in the lab translate into effective medical treatments.
Building Research Capacity: NRICMI fosters talent through training programs, fellowships, and hands-on research experiences for students, fellows, and early-career scientists, building capacity for future healthcare innovations.
Advanced Wound Healing Research: Recent studies on hydrogel matrices infused with active metabolites have shown promising results for antibacterial and tissue-regenerative applications in wound healing.
Antibiotic Resistance Studies: Innovative research focusing on monitoring of circulating resistant genes and resensitizing resistant bacteria to antibiotics offers potential strategies to combat multidrug-resistant infections.
Genomic Research on Vascular Diseases: In partnership with various research centres, NRICMI is conducting comparative genomics and transcriptomics projects to identify the genetic basis of vascular diseases, aiming to develop precision medicine approaches for conditions like atherosclerosis, chronic venous diseases and deep vein thrombosis.
NRICMI envisions becoming a global leader in healthcare innovation by advancing research in regenerative medicine, infectious disease, chronic venous disease management, and molecular microbiology. Through collaboration, interdisciplinary research, and community engagement, NRICMI seeks to make healthcare more effective, accessible, and personalized.
To pioneer innovative research methodologies aimed at unravelling the complexities of venous diseases, their etiology and progression
To drive advancements in medical technology and treatment modalities and to develop novel therapeutic interventions for venous diseases
To serve as a catalyst for interdisciplinary collaboration, bringing together experts from various fields including molecular biology, genetics, nanobiotechnology, and vascular imaging
To facilitate knowledge translation and dissemination through educational programs, workshops, and outreach initiatives connecting with healthcare professionals, policymakers, and the public
To foster a culture of innovation and entrepreneurship within the medical community, empowering researchers, clinicians, and medical students to explore creative solutions to pressing healthcare challenges
To promote ethical and responsible research practices that adhere to the highest standards of integrity, transparency, and patient safety, and contribute to the advancement of medical science for the benefit of society as a whole
To actively engage with industry partners, government agencies, and philanthropic organizations to secure sustainable funding and resources for the centre's activities